Skip to content
drillr.ai
Sign up

JNJ

JOHNSON & JOHNSON

NYSE · Healthcare · Drug Manufacturers - General · US

$269.99
−0.09%
Ask drillr
0
Insider buys (3m)
9
Insider sells (3m)
-$64.7M
Net value (3m)
+16.5%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Sep 10, 2026HEWSON MARILLYN A · directorA-Award181$0.00
Sep 10, 2026Woods Eugene A. · directorA-Award136$0.00
Sep 10, 2026Pinto Daniel E · directorA-Award113$0.00
Sep 4, 2026Schmid Timothy · officer: EVP, WW Chair, MedTechSale22,527$275
Sep 4, 2026Schmid Timothy · officer: EVP, WW Chair, MedTechM-Exempt22,527$151
Sep 4, 2026Schmid Timothy · officer: EVP, WW Chair, MedTechM-Exempt11,070$132
Aug 18, 2026Taubert Jennifer L · officer: EVP, WWC. Innovative MedicineM-Exempt15,000$116
Aug 18, 2026Taubert Jennifer L · officer: EVP, WWC. Innovative MedicineSale15,000$263
Aug 14, 2026Duato Joaquin · director, officer: CEO and Chairman of the BoardM-Exempt123,291$116
Aug 14, 2026Duato Joaquin · director, officer: CEO and Chairman of the BoardSale20,976$262
Aug 14, 2026Duato Joaquin · director, officer: CEO and Chairman of the BoardSale102,315$261
Aug 7, 2026Forminard Elizabeth · officer: EVP, Chief Legal OfficerSale6,574$256
Aug 7, 2026Duato Joaquin · director, officer: CEO and Chairman of the BoardSale41,957$258
Aug 7, 2026Forminard Elizabeth · officer: EVP, Chief Legal OfficerSale9,344$258
Aug 7, 2026Forminard Elizabeth · officer: EVP, Chief Legal OfficerM-Exempt9,344$132
Aug 7, 2026Duato Joaquin · director, officer: CEO and Chairman of the BoardSale6,523$259
Jul 21, 2026Broadhurst Vanessa · officer: EVP, Global Corp AffairsM-Exempt11,925$132
Jul 21, 2026Broadhurst Vanessa · officer: EVP, Global Corp AffairsM-Exempt11,129$130
Jul 21, 2026Broadhurst Vanessa · officer: EVP, Global Corp AffairsSale23,054$251
Jun 12, 2026Wengel Kathryn E · officer: EVP, Chief TO and Risk OfficerM-Exempt10,000$116
Jun 12, 2026Wengel Kathryn E · officer: EVP, Chief TO and Risk OfficerSale10,000$241
Jun 11, 2026Woods Eugene A. · directorA-Award161$0.00
Jun 11, 2026HEWSON MARILLYN A · directorA-Award215$0.00
Jun 11, 2026Pinto Daniel E · directorA-Award134$0.00
May 4, 2026REED JOHN C · officer: EVP, Innovative Medicine, R&DF-InKind11,002$230
May 4, 2026REED JOHN C · officer: EVP, Innovative Medicine, R&DM-Exempt25,255$0.00
Apr 27, 2026WEINBERGER MARK A · directorA-Award975$0.00
Apr 27, 2026Pinto Daniel E · directorA-Award1,712$0.00
Apr 27, 2026Joly Hubert · directorA-Award975$0.00
Apr 27, 2026Doudna Jennifer A · directorA-Award975$0.00
Institutional positioning

13F filings over the trailing two quarters

New 523Increased 3756Reduced 4095Sold out 124
FilerActionSharesFiled
BLACKROCK, INC.Increased213,385,546May 13, 2026
BlackRock, Inc.Reduced212,098,264Aug 7, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased157,226,374Aug 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position156,605,370May 15, 2026
STATE STREET CORPIncreased133,776,025Aug 7, 2026
STATE STREET CORPReduced133,476,288May 15, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCIncreased64,370,816Aug 13, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCNew Position63,514,436May 8, 2026
JPMORGAN CHASE & COIncreased63,096,344May 13, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased59,164,862May 15, 2026
GEODE CAPITAL MANAGEMENT, LLCReduced59,086,417Aug 12, 2026
JPMORGAN CHASE & COReduced58,301,609Aug 12, 2026
MORGAN STANLEYIncreased44,808,254Aug 13, 2026
MORGAN STANLEYReduced44,721,167May 15, 2026
NORGES BANKNew Position31,825,084Aug 12, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 10, 2026